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Abstract
Aim: To minimize termination of resuscitation (TOR) in potential survivors, the desired positive predictive value (PPV) for mortality and specificity of
universal TOR-rules are 99%. In lack of a quantitative summary of the collective evidence, we performed a diagnostic meta-analysis to provide an
overall estimate of the performance of the basic and advanced life support (BLS and ALS) termination rules.
Data sources: We searched PubMed/EMBASE/Web-of-Science/CINAHL and Cochrane (until September 2019) for studies on either or both TOR-
rules in non-traumatic, adult cardiac arrest. PRISMA-DTA-guidelines were followed.
Results: There were 19 studies: 16 reported on the BLS-rule (205.073 patients, TOR-advice in 57%), 11 on the ALS-rule (161.850 patients, TOR-advice
in 24%). Pooled specificities were 0.95 (0.890.98) and 0.98 (0.951.00) respectively, with a PPV of 0.99 (0.991.00) and 1.00 (0.991.00).
Specificities were significantly lower in non-Western than Western regions: 0.84 (0.730.92) vs. 0.99 (0.970.99), p < 0.001 for the BLS rule. For the
ALS-rule, specificities were 0.94 (0.870.97) vs. 1.00 (0.991.00), p < 0.001. For non-Western regions, 16 (BLS) or 6 (ALS) out of 100 potential
survivors met the TOR-criteria. Meta-regression demonstrated decreasing performance in settings with lower rates of in-field shocks.
Conclusions: Despite an overall high PPV, this meta-analysis highlights a clinically important variation in diagnostic performance of the BLS and ALS
TOR-rules. Lower specificity and PPV were seen in non-Western regions, and populations with lower rates of in-field defibrillation. Improved insight in
the varying diagnostic performance is highly needed, and local validation of the rules is warranted to prevent in-field termination of potential survivors.
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Introduction
Over 300.000 out-of-hospital cardiac arrests (OHCA) occur annually
in Europe alone, and despite improvements in treatment most patients
do not survive.1 Appreciating the risks for emergency medical services
(EMS) personnel and the public, and the impact on healthcare
resources, emergency transport for refractory OHCA should prefera-
bly be justified by the expected benefit for the patient.2,3
To reduce futile hospital transportations, current cardiopulmonary
resuscitation (CPR)-guidelines reference two termination-of-
resuscitation (TOR) algorithms to discriminate between non-survivors
and survivors.4,5 The basic and advanced life support (BLS and ALS)
TOR-rules consist of a set of key arrest characteristics (in-field
defibrillation, witnessed arrest, bystander CPR or return of spontane-
ous circulation [ROSC], Fig. 1).6,7 In patients meeting 1 criteria, the
TOR-rules are considered negative, and transport is recommended. If
none of the criteria are present, the TOR-rule is considered positive
and termination can be considered.
The criteria on which the recommendation to transport is based are
all predictors of survival. Thus, in regions where many patients have
favorable arrest characteristics, transport rates will be higher than in
regions with less favorable characteristics.8 However, the factors used
in the TOR-rules do not account for all variability in outcome: other
factors such as age also impact survival. Therefore, their diagnostic
performance may vary according to the region of study conduction.9,10
In many previous studies a positive TOR-rule had a predictive value for
death of >99%, indicating a <1% chance of survival when a patient fulfils
the TOR-criteria.1114 This complies with an often referenced medical
futility rate of 1%.15,16However, other studies found that >10% of survivors
would have qualified for termination based on the TOR-rule.
1720 Further understanding of these discrepancies is of great importance
in an era where guidelines call for uniform and reliable TOR-rules.4,5
In this context, we performed a diagnostic meta-analysis to provide a
quantitativesynthesisof theoverallperformanceof theBLSandALSTOR-
rules to identify non-survivors of OHCA. In addition, we studied factors that
may explain the heterogeneity among studies through meta-regression,
where we focused on the impact of study region and the individual key
arrest characteristics that comprise the respective TOR-rules.
Methods
We followed the recommendations of the Cochrane Collaboration and
the preferred reporting items for systematic reviews and meta-analyses
of diagnostic test accuracy studies (PRISMA-DTA) statement.21,22
BLS and ALS TOR-rules
The BLS TOR-rule recommends transportation if a patient meets 1 of the
following criteria: in-field ROSC, shock delivered or EMS-witnessed arrest.
The ALS TOR-rule recommends transportation in case of in-field ROSC,
shock delivered, witnessed arrest and/or bystander CPR (Fig. 1).6,7
Search strategy
A systematic search was performed using Medline via PubMed,
EMBASE, Web-of-Science, CINAHL and The Cochrane Library. The
Fig. 1 – BLS and ALS TOR-rules.
Explanation of the studied TOR-rules; BLS left and ALS right. All criteria of the respective TOR-rules should be
considered prior to transportation or termination of the resuscitation effort. If any of the criteria is present, the rule
recommends transportation to the hospital. If none of the criteria is present, the rule recommends consideration of
termination of the resuscitation effort.
BLS = basic life support, ALS = advanced life support, TOR = termination of resuscitation, ROSC = return of spontaneous
circulation, EMS = emergency medical service, ED = emergency department, CPR = cardiopulmonary resuscitation.
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search query combined synonyms for OHCA with synonyms for TOR.
Two researchers (JN, GK) performed the searches independently. All
databases were searched from inception through September 11th,
2019. References of relevant articles were searched for additional
studies. The search strategy can be found in Supplemental text 1.
Study selection
We included all studies that applied the BLS and/or ALS TOR-rule to
an unselected cohort of non-traumatic adult OHCA patients. We
excluded studies that did not report or did not allow calculation of true
positive (TP), false positive (FP), true negative (TN) or false negative
(FN) rates for death and/or unfavourable neurologic outcome, as well
as conference abstracts. Exact duplicates were removed. Two
reviewers (JN, GK) independently assessed the eligibility of the
identified articles. Discrepancies were discussed with a third reviewer
(JLB) to reach consensus.
Quality assessment
Two reviewers (JN, GK) independently assessed the risk of bias and
study quality using the Quality Assessment of Diagnostic Accuracy
Studies (QUADAS-2) tool, as recommended by the PRISMA-DTA
group.22,23 Four domains were scored: (1) patient selection, (2)
index test, (3) reference standard, and (4) flow and timing, see
Supplemental Table 1. For our specific research question, in domain
4 we assessed whether or not all patients were transported to the
hospital. If not, the study is prone to verification bias, as patients that
are not transported to the hospital will by definition not survive to
discharge.
Data extraction and synthesis
Two investigators (JN, GK) independently extracted study data
using a pre-specified data collection form (Supplemental text 2).
Discrepancies were discussed with a third reviewer (JLB) to reach
consensus.
TP, FP, FN and TN values were summarized in 2  2 contingency
tables to (re)calculate diagnostic test characteristics (i.e. sensitivity,
specificity, positive predictive value [PPV], negative predictive value
[NPV] and transport rates). We followed the authors’ decision in which
rule they would use to report the test characteristics of their population.
If the rule recommended TOR, the test was regarded positive and if
the rule recommended transportation to the hospital, the test was
regarded negative.24 Consequently, death was considered “condition
present”. This results in the following 2  2 table:










Test characteristics of interest
In theory, the ideal TOR-rule would never recommend TOR in
surviving patients. Thus, specificity and PPV were regarded the test
characteristics of interest. Specificity is the probability that the rule
recommends transport in case the patient survives (=TN/FP + TN).
The PPV is the probability of death in case the rule proposes TOR
(=TP/TP + FP).
Transport rates
The observed transport rate was defined as the actual transport rate
as reported in the study (disregarding the TOR-rule). The projected
transport rate was defined as the transport rate in case the TOR-rule
would have been followed (=FN + TN/TP + FP + FN + TN).
Outcomes measures
Primary outcomes were the PPV and specificity for death, defined as
death in-hospital or at 30 days.25 Secondary outcomes were the PPV
and specificity for unfavourable neurologic outcome, defined as a
cerebral performance category 3.26
Statistical analysis
We used the data from the 2  2 tables to calculate sensitivity,
specificity, PPV and NPV for each study. We presented individual
study results by plotting sensitivity, specificity, PPV and NPV with 95%
confidence intervals in forest plots. We used a bivariate random-
effects approach for the meta-analysis of the pairs of sensitivity and
specificity and pairs of PPV and NPV.27,28 We investigated
heterogeneity visually by examining the forest plots and statistically
by including covariates in the bivariate models and by conducting pre-
specified subgroup and sensitivity analyses. The following sources of
heterogeneity were assessed 1) the effect of geographic region of
study conduction (i.e. non-Western vs. Western studies)29,30; 2) the
effect of the observed transport rate (i.e. 100% vs. <100%), 3)
QUADAS-2 risk of bias domains and 4) the individual components of
the analysed TOR-rule (Fig. 1). We incorporated these factors as
covariates in the bivariate models to examine the effect of potential
sources of bias and variation across subgroups of studies. Deeks’
tests and funnel plots were used to assess publication bias.31 For
analyses, we used R version 3.5.0 (R-Foundation for Statistical
Computing, Vienna, Austria) with the package “mada”.32
Results
We identified 1563 unique records after database searching. A
total of 19 individual studies were included (Supplemental
Fig. S1).68,1113,1720,3340 In total, 16 studies (205.073 patients)
reported on the BLS TOR-rule and 11 studies (161.850 patients)
reported on the ALS TOR-rule. Studies and patient characteristics
are outlined in Table 1 and Supplemental Table S2. All studies
were observational, ten of which were retrospective studies. As
can be seen in Table 1 baseline characteristics varied widely
among the studies (e.g. the proportion shockable initial rhythm
ranged from 10% to 47%). Outcomes also varied widely, with
survival ranging from 1.4% to 15.7%. There were two studies that
reported test characteristics for multiple sub-populations; in these,
we extracted data for which the level of care corresponds with the
rule. Thus, data on BLS-treated patients for the BLS-rule and
ALS-treated patients for the ALS-rule.17,18 Twelve of the included
studies had a maximum QUADAS-2 score and thus a low risk of
bias (Supplemental Table S1).6,7,12,13,1720,36,37,39,40 Seven
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1 Singapore Both Std or 30-days 2193 66 69 5 29 24 7 50 57 23 3.5
Chiang
(2015)
1 Taiwan BLS Std (both rules) 1727 72 64 4 10 30 12 5.7 5.7
ALS 240 71 60 29 13 35 27 6.5 9.2
Diskin
(2014)
1 United States ALS 1-month survival 322 63 59 39 33 16 48 64 34 12.1
Fukuda
(2014)
1 Japan BLS Std (both rules) 148 68 69 4 10 25 24 4.1
ALS 41 73 61 7 15 32 29 9.8
Grunau
(2017)
3 Canada BLS Std 6994 67 68 49 27 25 11 40 51 47 6.5 14.9
Jordan
(2017)
1 United States BLS Std 169 64 69 18 40 9 39 47 38 6.8 13.6
Kajino
(2013)
1 Japan BLS 1-month survival
(both rules)
151152 76 57 7 11 11 30 41 36 7.1 6.3
ALS 137986 74 60 5 12 5 36 41 42 7.3 4.0
Kashiura
(2016)




1 Korea BLS Std 4835 67 66 5 28 19 3 50 57 6.5 9.3
Lee
(2019)
3 Korea Both Std 4608 70 65 13 26 19 59 48 7 11.7
Morrison
(2006)
3 Canada BLS Std or 6-months* 1240 69 69 6 30 10 46 57 27 8.0 3.3
Morrison
(2007)
2 Canada Both Std 4673 69 66 18 10 5.1
Morrison
(2009)
2 United States/Canada Both Std 2415 69 63 19 30 9 38 47 28 5.4
Ong
(2006)
2 Canada BLS Std 13684 69 67 11 43 37 8 45 52 17 6.7 4.7
Ong
(2007)
2 Singapore BLS Std or 30-days 2269 61 68 2 22 19 10 55 65 21 10.0 1.4
Ruygrok
(2009)
1 United States Both Std with
CPC  2
715 65 69 31 42 30 8 41 49 25 6 5.9
Sasson
(2008)
2 United States Both Std 5505 64 60 31 24 12 37 50 21 7.1
Verbeek
(2002)
1 Canada BLS Std 662 72 61 5 25 13 40 52 16 6.7 2.0
Verhaert
(2016)
1 The Netherlands ALS Std 598 66 69 47 60 47 10 63 73 54 8 15.7
StudyandPatients characteristics. In caseof application of theTOR-rule tomultiple sub-populations in onestudy,weextracted the data from the sub-set of patientsmost comparable to the original target population of the rule (i.e.
for the BLS-rule we preferably used patients resuscitated by BLS-providers, and for the ALS-rule we preferably used patients resuscitated by ALS-providers). y = Design category: 1 = Retrospective study, 2 = Retrospective
analysis of prospectively collected data, 3 = Prospective study. * = Alive in-hospital at 6months. TOR= termination of resuscitation, Std = survival to discharge, CPC=cerebral performance category, EMS=emergencymedical































studies were at risk of bias in the domain “Flow and timing”,
because not all patients were transported to the hospital (transport
rate <100%).8,11,14,3335,38 No evidence of publication bias was
found using Deeks’ funnel plots and Deeks’ test (Supplemental
Fig. S2).
Diagnostic accuracy for death
BLS TOR-rule
Sixteen studies reported on a total of 205.073 patients.6,7,1114,
1720,3540 Test characteristics and forest plots are shown in Fig. 2.
The pooled specificity and sensitivity for all studies were 0.95 (95% CI
0.890.98) and 0.66 (0.610.70), respectively. The pooled PPV and
NPV were 0.99 (0.991.00) and 0.14 (0.100.19), respectively. The
mean projected transport rate was 43% and ranged from 25% to 79%,
as shown in Supplemental Table 3.
ALS TOR-rule
Eleven studies reported on 161.850 patients.7,8,11,17,18,3437,39,40 Test
characteristics and forest plots are shown in Fig. 2. The pooled specificity
and sensitivity for all studies were 0.98 (0.951.00) and 0.26 (0.21
0.32), respectively. The pooled PPV and NPV were 1.00 (0.991.00)
and 0.09 (0.070.12), respectively. The mean projected transport rate
was 76% and ranged from 66% to 94% (Supplemental Table S3).
Diagnostic accuracy for unfavourable neurologic outcome
For these analyses we studied the subset of studies that reported on
neurologic outcome.
BLS TOR-rule
Nine studies reported on 173.224 patients.11,12,17,19,33,36,37,39,40 Test
characteristics and forest plots are shown in Fig. 3. The pooled
specificity and sensitivity for all studies were 0.96 (0.930.98) and
0.65 (0.560.74), respectively. The pooled PPV and NPV were 1.00
(1.001.00) and 0.11 (0.080.16), respectively.
ALS TOR-rule
Eight studies reported on 154.608 patients (Fig. 3).11,17,18,33,36,37,39,40
The pooled specificity and sensitivity for all studies were 0.98
(0.960.99) and 0.27 (0.230.30), respectively. The pooled PPV and
NPV were 1.00 (0.991.00) and 0.05 (0.030.08), respectively.
Subgroup and meta-regression analyses
BLS TOR-rule
For studies conducted in Western regions (n = 8) vs. studies in non-
Western regions (n = 8), the pooled specificity was 0.99 (0.970.99)
vs. 0.84 (0.730.92), p < 0.001 and PPV was 1.00 (1.001.00) vs.
0.99 (0.970.99), p = 0.008 (Table 2a). In studies with a transport rate
of 100% (n = 12) vs. studies with a transport rate <100% (n = 4), the
specificity was 0.93 (0.840.97) vs. 0.98 (0.931.00) (p = 0.09) and
PPV was 0.99 (0.991.00) vs. 1.00 (0.981.00) (p = 0.75). A transport
rate of <100% was the only source of bias, which has been addressed
in the aforementioned analyses. Therefore, no further analyses were
performed according to the QUADAS-2 score.
Meta-regression indicated that the specificity increased
(p = 0.03) with an increasing proportion of patients that received a
shock during the resuscitation. ROSC and EMS witnessed status
were not significantly associated with the specificity or PPV
(Supplemental Table 4a).
ALS TOR-rule
For studies conducted in Western regions (n = 5) vs. studies
conducted in non-Western regions (n = 6), the specificity was 1.00
(0.991.00) vs. 0.94 (0.870.97), p < 0.001 and the PPV 1.00
(1.001.00) vs. 0.99 (0.980.99), p < 0.001 (Table 2b). In studies
with a transport rate of 100% (n = 7) vs. studies with a transport
rate <100% (n = 4), the pooled specificity was 0.96 (95% CI
0.900.98) vs. 1.00 (0.991.00), p = 0.005 and the pooled PPV
0.99 (0.981.00) vs. 1.00 (0.991.00), p = 0.02. A transport rate











































































































































































































































































































































0 0.25 0.5 0.75 1 0 0 .25 0.5 0.75 1 0 0.25 0.5 0.75 1 0 0.25 0.5 0.75 1
Fig. 2 – Forest plots of diagnostic accuracy for death in-hospital or at 30-days of the BLS and ALS TOR-rules.
Test characteristics of the TOR-rules for the primary outcome, for individual studies and pooled values. ALS = advanced
life support, TOR = termination of resuscitation, TP = True positive, FP = False positive, TN = True negative, FN = False
negative, CI = confidence interval, PPV = positive predictive value, NPV = negative predictive value.
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the aforementioned analyses. Therefore, no further analyses were
performed according to the QUADAS-2 score.
Meta-regression indicated that the specificity increased with an
increasing proportion of patients that received a shock (p = 0.002) or
regained ROSC (p = 0.03) during the resuscitation. Witnessed status
and bystander CPR were not associated with the specificity. No
factors were significantly associated with the PPV (Supplemental
Table S4b).
Discussion
In this in-depth diagnostic meta-analysis and systematic review on
over 350.000 patients, we assessed the diagnostic performance of the
two guideline-endorsed TOR-rules to identify non-survivors of OHCA.
The pooled PPV of 0.99 for the BLS (95% CI 0.991.00) and 1.00 for





























































































































































































































0 0.25 0.5 0.75 1 0 0.25 0.5 0.75 1 0 0.25 0.5 0.75 1 0 0.25 0.5 0.75 1
Fig. 3 – Forest plots of diagnostic accuracy for unfavourable neurologic outcome of the BLS and ALS TOR-rules.
Test characteristics of the BLS and ALS TOR-rules for unfavourable neurological outcome, for individual studies and
pooled values. BLS = basic life support, ALS = advanced life support, TOR = termination of resuscitation, TP = True
positive, FP = False positive, TN = True negative, FN = False negative, CI = confidence interval, PPV = positive
predictive value, NPV = negative predictive value.
Table 2a – Subgroup analysis BLS TOR-rule.
Studies n Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI)
All 16 0.66 (0.610.70) 0.95 (0.890.98) 0.99 (0.991.00) 0.14 (0.100.19)
Transport rate 100% (low risk of bias) 12 0.68 (0.630.73) 0.93 (0.840.97) 0.99 (0.991.00) 0.12 (0.090.17)
<100% (high risk of bias) 4 0.59 (0.490.68) 0.98 (0.930.99) 1.00 (0.981.00) 0.20 (0.110.33)
p-Value 0.09 0.10 0.75 0.17
Region Western 8 0.59 (0.540.64) 0.99 (0.970.99) 1.00 (1.001.00) 0.13 (0.080.20)
Non-Western 8 0.72 (0.680.76) 0.84 (0.730.92) 0.99 (0.970.99) 0.15 (0.100.23)
p-Value <0.001 <0.001 0.008 0.67
Subgroup analysis of the BLS TOR-rule. We defined Western regions as Europe, North-America and Australia; and non-Western regions as all other
countries.29,30
BLS = basic life support, TOR = termination of resuscitation, PPV = positive predictive value, NPV = negative predictive value, CI = confidence interval.
Table 2b – Subgroup analysis ALS TOR-rule.
Studies n Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI)
All 11 0.26 (0.210.32) 0.98 (0.951.00) 1.00 (0.991.00) 0.09 (0.070.12)
Transport rate 100% (low risk of bias) 7 0.29 (0.220.36) 0.96 (0.900.98) 0.99 (0.981.00) 0.08 (0.060.10)
<100% (high risk of bias) 4 0.21 (0.150.29) 1.00 (0.991.00) 1.00 (0.991.00) 0.12 (0.080.17)
p-Value 0.15 0.005 0.02 0.10
Region Western 5 0.23 (0.170.31) 1.00 (0.991.00) 1.00 (1.001.00) 0.11 (0.070.15)
Non-Western 6 0.28 (0.210.37) 0.94 (0.870.97) 0.99 (0.980.99) 0.08 (0.050.11)
p-Value 0.32 <0.001 <0.001 0.22
Subgroup analysis of the ALS TOR-rule. We defined Western regions as Europe, North-America and Australia; and non-Western regions as all other
countries.29,30
ALS = advanced life support, TOR = termination of resuscitation, PPV = positive predictive value, NPV = negative predictive value, CI = confidence interval.
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either rule advises in-field TOR. However, we found a clinically
important variation in specificity, which indicates that among
survivors, there was a wide range in the proportion of patients that
qualified for in-field TOR. The pooled specificity was lowest in non-
Western regions, where 16 (BLS-rule) or 6 (ALS-rule) out of 100
survivors met the TOR-criteria. In addition to region, the only
component of the TOR-rule associated with specificity of both rules
was the proportion of patients with in-field shocks. The heterogeneity
in performance of the TOR-rules calls for evaluation of the TOR-rule in
the intended region before actual implementation to avoid TOR in
potential survivors.
Diagnostic performance
For both TOR-rules, the cumulative available evidence indicates a
pooled PPV of 0.99, for both outcome measures (death; unfav-
ourable neurologic outcome). Fig. 2 demonstrates that there is little
heterogeneity and that confidence intervals are narrow (0.991.00 for
both rules). This indicates that overall chances of survival among
patients fulfilling the TOR-criteria is 1%. This complies with a
previously postulated medical futility criterion stating that further
treatment may be withheld if survival chances are <1%.15 We refer to
this 1% as a reference as it is the most commonly used criterion for
futility, that has also been used during the development of the TOR-
rules and is referenced in guidelines.5,6,12,16 However, it should be
noted that this definition has been questioned, particularly in the field
of resuscitation, and therefore remains an important topic of debate. In
such discussions, ethical and religious dimensions should be taken
into consideration.4 Importantly, the PPV was high irrespective of
study region and population characteristics.
However, our findings were less consistent regarding specificity,
for which the pooled values were high, but confidence intervals wider
and forest plots more heterogeneous. Among the included studies,
specificity ranged from 70 to 100%, which indicates that up to 30% of
all survivors fulfil the TOR-criteria (Fig. 2). To gain insight into this
variation, we performed several pre-specified sensitivity and meta-
regression analyses in which we focused on population character-
istics and region.
The most striking result is the significant and clinically relevant
lower specificity in non-Western regions. Notably, these are all Asian
regions, in which the pooled specificity of the BLS and ALS-rule were
0.84 and 0.94, indicating that 16 and 6 out of every 100 survivors fulfil
the TOR-criteria.
One major difference between Western and non-Western regions is
that in several Western regions TOR is legally allowed, in contrast to
non-Western regions. Consequently, all non-Western, but only half of
the Western studies had a transport rate of 100%. In some Western
regions, local legislation permits cessation of CPR-attempts in case of
asystole despite >20 min. of full treatment.41,42Such cases are likely to
receive a termination advice according to the ALS and BLS TOR-rules
as well. This may induce a “self-fulfilling prophecy” due to verification
bias. More specifically, partial verification bias, as not all patients that
are subjected to the investigated test (TOR-rule) are subjected to the
reference test, i.e. the “test” whether they would survive in case of
transportation.43 If all patients had been transported, it is possible that
there would have been a few that would have survived.
Therefore, the reported specificity and PPV may be an overestima-
tion of the situation as it would have been when all patients are
transported. This is supported by the fact that we found a higher
proportion patients with a TOR-advice among survivors in non-Western
vs. Western countries (BLS and ALS-rule) and in countries with a
transport rate of 100% vs. <100% (ALS-rule). However, additional
study is warranted to address this issue. Furthermore, as specificities
did not differ to the same extent in comparisons between studies with
100% vs. <100% transport rates and comparisons on non-Western vs.
Western studies, it seems unlikely that transport rate is the sole
explanation for our findings, particularly for the BLS-rule.
Several other explanations can be mentioned. First, meta-
regression demonstrated that specificity is lower in studies with lower
proportions of patients with in-field defibrillation attempts. The lower
proportion of patients with in-field defibrillation attempts in the non-
Western countries (median 20% in non-Western vs. 30% in Western
regions, p = 0.001) is thus likely to have contributed to the lower
specificity.44 Second, the time between start CPR and assessment of
the TOR-criteria may be an important factor. Previous studies showed
that chances of falsely recommending TOR decrease with increasing
time to TOR-assessment.19,38,45 For example, patients without
ROSC/defibrillation after 5 min have higher survival chances than
after 20 min, and therefore early application of the rule may result in
undesired termination-advice. Asian regions often apply a scoop-and-
run strategy, with short in-field CPR-duration (24 min. in most Asian
regions a recent study),46 and possibly earlier application of the TOR-
rules. Previous Asian studies indeed showed that specificity
decreased with decreasing time to TOR-rule application.19,45
However, in absence of uniform reporting of these time intervals
statistical analyses on this hypothesis were not feasible.
Thirdly, patients that meet TOR-criteria may have a higher chance of
being salvaged in non-Western regions, which may be due to different
underlying aetiologies, more patients that have pulseless electrical
activity instead of asystole, or widespread use of advanced CPR-
techniques.47,48 Finally, the lower specificity was only found for death,
and not for the secondary endpoint of unfavourable neurologic outcome.
The lower specificity could hypothetically be driven by patients surviving
withanimpairedneurologicstatus.49However,asnotall studiesreporton
neurologic outcome, these results should be interpreted with caution and
the exact cause of the lower specificity remains to be elucidated.
Overall, the NPV and sensitivity were low (Fig. 2). This indicates
that, even when following the TOR-rules, there would still be many
transports of non-surviving patients. This is important in light of the
recent proposal to use TOR-rules to identify candidates for extracorpo-
real CPR (eCPR).50 If a negative TOR-rule would be used as the only
criterion for eCPR, all transported patients wouldbeeligible for eCPR, of
which the a priori chance of survival is low. Therefore, the suggestion to
use the TOR-rule as initial screening tool for rapid transport, followed by
a secondary assessment on the emergency department to assess age,
co-morbidity etc. as secondary criteria for eCPR seems sensible.50 On
the other hand, a lower threshold for early transport may also adversely
affect survival chances, due to the sometimes suboptimal CPR-
quality.60 In this context, comparative trials are of utmost importance.
Our study builds on a previous meta-analysis on this topic. In
contrast to the current quantitative synthesis, that study excluded
studies with in-field TOR. In addition, PPV and NPV were not reported.
The current analysis covers all available evidence, to specifically focus
on heterogeneity in performance, as well as the related factors.51
Post-hoc analysis on diagnostic performance in relation to
projected transport rate
Appreciating that the projected transport rate is higher in case of
favourable, and lower in case of more unfavourable arrest
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Fig. 4 – Diagnostic performance of the BLS TOR-rule in relation to population characteristics.
Figures that demonstrate that the diagnostic performance of the BLS-TOR rule is related to characteristics of the
studied population. a) Specificity is the proportion transport advice among survivors; 1-specificity is thus the
proportion termination advice among survivors. Sensitivity is the proportion termination advice among non-survivors.
As the projected transport rate is the proportion patients that fulfil at least one criterion of the BLS TOR-rule (in-field
shocks, EMS witnessed or ROSC), this can be used as a measure for general favourability of the characteristics of the
studied population. b) Graphical illustration of the classification of 100 survivors in setting with favourable,
intermediate and unfavourable population characteristics, defined as tertiles of the projected transport rate. The
numbers are the numbers of the references. BLS = basic life support, TOR = termination of resuscitation,
EMS = emergency medical services, ROSC = return of spontaneous circulation.
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characteristics,9 this rate can be considered a proxy for overall
population arrest characteristics.8 Of the individual components of the
TOR-rules, mainly in-field shock was found to be associated with the
specificity.
In a post-hoc analysis, we tried to gain more insight into the
association between population characteristics and the diagnostic
performance, by constructing Fig. 4. In this figure, sensitivity and
specificity are plotted against the projected transport rate for the BLS
TOR-rule, which is the proportion of patients fulfilling at least one of its
criteria (ROSC, shock, EMS witnessed). This figure shows that in
studies with favourable population characteristics (i.e. high projected
transport rate), specificity is almost 1.00, indicating that TOR-advice
among survivors is rare, whereas the sensitivity of around 0.50
indicates that about half of the unsalvageable patients should be
transported when following the rule. The opposite goes for studies with
less favourable characteristics (i.e. lower transport rate): TOR-advice
in up to 30% of survivors due to low specificity, but markedly less futile
transportations due to higher sensitivity. Similar associations were
found for the ALS TOR-rule (not shown). Thus, the overall baseline
profile of the population seems to affect its diagnostic performance.
Implications
In this most comprehensive summary of evidence to date we
demonstrate a large variation in diagnostic performance of the TOR-
rules. This variation should be acknowledged in practice guidelines on
this topic. Furthermore, additional study on the optimal TOR-strategy
is essential to further facilitate evidence-based decision making in the
pre-hospital setting. This particularly applies to non-Western regions
and regions with low proportions in-field defibrillation. As discussed
previously, in future studies all OHCA-victims should be transported to
the hospital to avoid verification bias. However, it should be noted that
in such studies there is a trade-off between the optimal study setting
(transporting all patients) and the purpose for which the rules are
designed (reducing futile transport). Second, given the association
between baseline profile, time to assessment of TOR-criteria19,38 and
diagnostic performance, these should be reported uniformly. For
instance, some studies actually report the proportion of patients
receiving an in-field shock, whereas others report on the proportion of
patients with an initial shockable rhythm. Third, the performance of
future TOR rules may be improved by incorporating other variables,
such as arrest-duration, age or chest compression quality.5255 In
addition, incorporation of clinician’s judgement has been suggested
as well.56 Our findings indicate that there is room for improvement,
thus optimizing existing TOR-algorithms or developing new TOR-
rules remains an important topic for further research. Fourth, future
studies should not only focus on PPV but also on specificity, in which
we found the largest variation. This presumably relates to the low
survival rates in the included studies, which is further explained in
Supplemental text 3.
In Western regions the overall PPV and specificity were high.
However, not all studies were performed with a 100% transportation
rate, hampering the interpretability of the results. Furthermore, the
landscape of cardiac arrest treatment is rapidly evolving, e.g. due to
increased use of lay-person automated external defibrillators and
bystander CPR, or newer technologies such as mechanical CPR and
extra corporeal life support.5761 Probably due to these develop-
ments, survival rates are also increasing, from 2% in the derivation
study to up to 15% in more recent studies.6,8,38 Our results implicate
that that the overall baseline profile might affect the diagnostic
performance of the rules. Therefore, we provide an evidence-based
support for the resuscitation guideline recommendation of locally
evaluation of the intended TOR-rule before actual implementation.62
This should be done in a setting that is comparable to the
contemporary pre-hospital care, and ideally in a setting where all
patients are transported to the hospital.
Limitations
It was inherent to the objective of this report that the included studies
were of observational design and thus all limitations generally
ascribed to observational research apply. Many studies were
retrospective, possibly limiting the quality and uniformity of collected
data (Table 1). This should be a top priority in further studies on this
topic. Furthermore, although we performed several sub-analyses and
meta-regression analyses, residual confounders may have affected
the reported diagnostic accuracy, such as CPR-quality, quality of post-
resuscitation care etc. Moreover, the quality of the included studies
varied, with verification bias being a major concern, which we
addressed in our sub-analyses. Not all studies reported on survival to
discharge. Therefore, we used the endpoints as reported in the
original studies, which was either survival to discharge or 30-day
survival, which comply with the Utstein recommendations.25 Although
all analyses were prespecified, we did not formally register our study
protocol. Lastly, the presented performances of the TOR-rules apply
to adult non-traumatic OHCA, which precludes extrapolation to other
populations.
Conclusions
In the present systematic review and diagnostic meta-analysis we
found that despite an overall high PPV, there is a clinically important
variation in the diagnostic performance of the BLS and ALS TOR-
rules. Lower specificity and PPV were seen in non-Western regions,
and populations with lower rates of in-field defibrillation. The observed
regional variation calls for local validation of the TOR-rules before
clinical use, and improved insight into how to reduce the risk of a
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Appendix A. Supplementary data
Supplementary material related to this article can be found, in the online
version, at doi:https://doi.org/10.1016/j.resuscitation.2019.12.016.
R E F E R E N C E S
1. Grasner JT, Lefering R, Koster RW, et al. EuReCa ONE-27 Nations,
ONE Europe, ONE Registry: A prospective one month analysis of out-
of-hospital cardiac arrest outcomes in 27 countries in Europe.
Resuscitation 2016;105:18895.
2. Maguire BJ, Hunting KL, Smith GS, Levick NR. Occupational fatalities
in emergency medical services: a hidden crisis. Ann Emerg Med
2002;40:62532.
3. Cheung M, Morrison L, Verbeek PR. Prehospital vs. emergency
department pronouncement of death: a cost analysis. Cjem
2001;3:1925.
4. Bossaert LL, Perkins GD, Askitopoulou H, et al. European
Resuscitation Council Guidelines for Resuscitation 2015: Section 11.
The ethics of resuscitation and end-of-life decisions. Resuscitation
2015;95:30211.
5. Mancini ME, Diekema DS, Hoadley TA, et al. Part 3: Ethical Issues:
2015 American Heart Association Guidelines update for
cardiopulmonary resuscitation and emergency cardiovascular care.
Circulation 2015;132:S38396.
6. Verbeek PR, Vermeulen MJ, Ali FH, et al. Derivation of a termination-
of-resuscitation guideline for emergency medical technicians using
automated external defibrillators. Acad Emerg Med 2002;9:6718.
7. Morrison LJ, Verbeek PR, Vermeulen MJ, et al. Derivation and
evaluation of a termination of resuscitation clinical prediction rule for
advanced life support providers. Resuscitation 2007;74:26675.
8. Verhaert DV, Bonnes JL, Nas J, et al. Termination of resuscitation in
the prehospital setting: A comparison of decisions in clinical practice
vs. recommendations of a termination rule. Resuscitation
2016;100:605.
9. Sasson C, Rogers MA, Dahl J, Kellermann AL. Predictors of survival
from out-of-hospital cardiac arrest: a systematic review and meta-
analysis. Circ Cardiovasc Qual Outcomes 2010;3:6381.
10. Rea TD, Cook AJ, Stiell IG, et al. Predicting survival after out-of-
hospital cardiac arrest: role of the Utstein data elements. Ann Emerg
Med 2010;55:24957.
11. Sasson C, Hegg AJ, Macy M, et al. Prehospital termination of
resuscitation in cases of refractory out-of-hospital cardiac arrest. Jama
2008;300:14328.
12. Morrison LJ, Visentin LM, Kiss A, et al. Validation of a rule for
termination of resuscitation in out-of-hospital cardiac arrest. N Engl J
Med 2006;355:47887.
13. Ong ME, Jaffey J, Stiell I, Nesbitt L. Comparison of termination-of-
resuscitation guidelines for basic life support: defibrillator providers in
out-of-hospital cardiac arrest. Ann Emerg Med 2006;47:33743.
14. Jordan MR, O’Keefe MF, Weiss D, et al. Implementation of the
universal BLS termination of resuscitation rule in a rural EMS system.
Resuscitation 2017;118:7581.
15. Schneiderman LJ, Jecker NS, Jonsen AR. Medical futility: its meaning
and ethical implications. Ann Intern Med 1990;112:94954.
16. Morrison LJ, Kierzek G, Diekema DS, et al. Part 3: ethics: 2010
American Heart Association Guidelines for Cardiopulmonary
Resuscitation and Emergency Cardiovascular Care. Circulation
2010;122:S66575.
17. Fukuda T, Ohashi N, Matsubara T, et al. Applicability of the
prehospital termination of resuscitation rule in an area dense with
hospitals in Tokyo: a single-center, retrospective, observational
study: is the pre hospital TOR rule applicable in Tokyo? Am J Emerg
Med 2014;32:1449.
18. Chiang WC, Ko PC, Chang AM, et al. Predictive performance of
universal termination of resuscitation rules in an Asian community: are
they accurate enough? Emerg Med J 2015;32:31823.
19. Kim TH, Shin SD, Kim YJ, Kim CH, Kim JE. The scene time interval and
basic life support termination of resuscitation rule in adult out-of-hospital
cardiac arrest. J Korean Med Sci 2015;30:1049.
20. OngME,TanEH,NgFS,etal.Comparison of termination-of-resuscitation
guidelines for out-of-hospital cardiac arrest in Singapore EMS.
Resuscitation 2007;75:24451.
21. Rutjes AWS, Reitsma JB, Whiting P, Vlassov VV, Leeflang MMG,
Deeks JJ. Chapter 9: Assessing methodological quality. In: Deeks JJ,
Bossuyt PM, Gatsonis C, editors. Cochrane Handbook for Systematic
Reviews of Diagnostic Test Accuracy Version 1.0.0. The Cochrane
Collaboration; 2009. . Available from: http://srdta.cochrane.org/.
22. McInnes MDF, Moher D, Thombs BD, et al. Preferred reporting items
for a systematic review and meta-analysis of diagnostic test accuracy
studies: The PRISMA-DTA statement. Jama 2018;319:38896.
23. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised
tool for the quality assessment of diagnostic accuracy studies. Ann
Intern Med 2011;155:52936.
24. Morrison LJ, Bigham BL, Kiss A, Verbeek PR. Termination of
resuscitation: a guide to interpreting the literature. Resuscitation
2008;79:38790.
25. Perkins GD, Jacobs IG, Nadkarni VM, et al. Cardiac arrest and
cardiopulmonary resuscitation outcome reports: update of the Utstein
Resuscitation Registry Templates for Out-of-Hospital Cardiac Arrest:
a statement for healthcare professionals from a task force of the
International Liaison Committee on Resuscitation (American Heart
Association, European Resuscitation Council, Australian and New
Zealand Council on Resuscitation, Heart and Stroke Foundation of
Canada, InterAmerican Heart Foundation, Resuscitation Council of
Southern Africa, Resuscitation Council of Asia); and the American
Heart Association Emergency Cardiovascular Care Committee and
the Council on Cardiopulmonary, Critical Care, Perioperative and
Resuscitation. Circulation 2015;132:1286300.
26. Jennett B, Bond M. Assessment of outcome after severe brain
damage: A practical scale. The Lancet 1975;305:4804.
27. Reitsma JB, Glas AS, Rutjes AW, et al. Bivariate analysis of sensitivity
and specificity produces informative summary measures in diagnostic
reviews. J Clin Epidemiol 2005;58:98290.
28. Leeflang MM, Deeks JJ, Rutjes AW, Reitsma JB, Bossuyt PM.
Bivariate meta-analysis of predictive values of diagnostic tests can be
an alternative to bivariate meta-analysis of sensitivity and specificity. J
Clin Epidemiol 2012;65:108897.
29. Hayashi M, Shimizu W, Albert CM. The spectrum of epidemiology
underlying sudden cardiac death. Circ Res 2015;116:1887906.
30. Reddy KS. Cardiovascular disease in non-Western countries. N Engl J
Med 2004;350:243840.
31. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication
bias and other sample size effects in systematic reviews of diagnostic
test accuracy was assessed. J Clin Epidemiol 2005;58:88293.
32. Doebler P. Meta-Analysis of Diagnostic Accuracy. R package version
0.5.8. 2017. https://CRAN.R-project.org/package=mada.
33. Ruygrok ML, Byyny RL, Haukoos JS. Validation of 3 termination of
resuscitation criteria for good neurologic survival after out-of-hospital
cardiac arrest. Ann Emerg Med 2009;54:23947.
34. Diskin FJ, Camp-Rogers T, Peberdy MA, Ornato JP, Kurz MC.
External validation of termination of resuscitation guidelines in
the setting of intra-arrest cold saline, mechanical CPR, and
comprehensive post resuscitation care. Resuscitation
2014;85:9104.
35. Morrison LJ, Verbeek PR, Zhan C, Kiss A, Allan KS. Validation of a
universal prehospital termination of resuscitation clinical prediction
rule for advanced and basic life support providers. Resuscitation
2009;80:3248.
36. Cheong RW, Li H, Doctor NE, et al. Termination of resuscitation rules
to predict neurological outcomes in out-of-hospital cardiac arrest for an
intermediate life support prehospital system. Prehosp Emerg Care
2016;20:6239.
12 R E S U S C I T A T I O N 1 4 8 ( 2 0 2 0 ) 3 1 3
37. Kashiura M, Hamabe Y, Akashi A, et al. Applying the termination of
resuscitation rules to out-of-hospital cardiac arrests of both cardiac
and non-cardiac etiologies: a prospective cohort study. Crit Care
2016;20:49.
38. Grunau B, Taylor J, Scheuermeyer FX, et al. External validation of the
universal termination of resuscitation rule for out-of-hospital cardiac
arrest in British Columbia. Ann Emerg Med 201770: 374-81.e1.
39. Kajino K, Kitamura T, Iwami T, et al. Current termination of
resuscitation (TOR) guidelines predict neurologically favorable
outcome in Japan. Resuscitation 2013;84:549.
40. Lee DE, Lee MJ, Ahn JY, et al. New termination-of-resuscitation
models and prognostication in out-of-hospital cardiac arrest using
electrocardiogram rhythms documented in the field and the
emergency department. J Korean Med Sci 2019;34:e134.
41. Baskett PJ, Steen PA, Bossaert L. European Resuscitation
Council guidelines for resuscitation 2005. Section 8. The ethics
of resuscitation and end-of-life decisions. Resuscitation 2005;67:
S17180.
42. Bailey ED, Wydro GC, Cone DC. Termination of resuscitation in the
prehospital setting for adult patients suffering nontraumatic cardiac
arrest. National Association of EMS Physicians Standards and Clinical
Practice Committee. Prehosp Emerg Care 2000;4:1905.
43. O’Sullivan JW, Banerjee A, Heneghan C, Pluddemann A. Verification
bias. BMJ Evidence-Based Medicine 2018;23:545.
44. Berdowski J, Berg RA, Tijssen JG, Koster RW. Global incidences of
out-of-hospital cardiac arrest and survival rates: Systematic review of
67 prospective studies. Resuscitation 2010;81:147987.
45. Goto Y, Funada A, Maeda T, Okada H, Goto Y. Field termination-of-
resuscitation rule for refractory out-of-hospital cardiac arrests in
Japan. J Cardiol 2019;73:2406.
46. Lin CH, Ng YY, Chiang WC, et al. Variation of current protocols for
managing out-of-hospital cardiac arrest in prehospital settings among
Asian countries. J Formos Med Assoc 2016;115:62838.
47. Chen N, Callaway CW, Guyette FX, et al. Arrest etiology among
patients resuscitated from cardiac arrest. Resuscitation
2018;130:3340.
48. Bergstrom M, Schmidbauer S, Herlitz J, Rawshani A, Friberg H.
Pulseless electrical activity is associated with improved survival in out-
of-hospital cardiac arrest with initial non-shockable rhythm.
Resuscitation 2018;133:14752.
49. Goto Y, Funada A, Maeda T, Okada H, Goto Y. Field termination-of-
resuscitation rule for refractory out-of-hospital cardiac arrests in
Japan. J Cardiol 2019;73:2406.
50. Morrison LJ. Prehospital termination of resuscitation rule. Curr Opin
Crit Care 2019;25:199203.
51. Ebell MH, Vellinga A, Masterson S, Yun P. Meta-analysis of the
accuracy of termination of resuscitation rules for out-of-hospital
cardiac arrest. Emerg Med J 2019;36:47984.
52. Nagao K, Nonogi H, Yonemoto N, et al. Duration of prehospital
resuscitation efforts after out-of-hospital cardiac arrest. Circulation
2016;133:138696.
53. Wissenberg M, Folke F, Hansen CM, et al. Survival after out-of-
hospital cardiac arrest in relation to age and early identification of
patients with minimal chance of long-term survival. Circulation
2015;131:153645.
54. Reynolds JC, Grunau BE, Rittenberger JC, et al. Association between
duration of resuscitation and favorable outcome after out-of-hospital
cardiac arrest: Implications for prolonging or terminating resuscitation.
Circulation 2016;134:208494.
55. Wik L, Kramer-Johansen J, Myklebust H, et al. Quality of
cardiopulmonary resuscitation during out-of-hospital cardiac arrest.
Jama 2005;293:299304.
56. Druwé P, Monsieurs KG, Piers R, et al. Perception of inappropriate
cardiopulmonary resuscitation by clinicians working in emergency
departments and ambulance services: The REAPPROPRIATE
international, multi-centre, cross sectional survey. Resuscitation
2018;132:1129.
57. Hansen CM, Lippert FK, Wissenberg M, et al. Temporal trends in
coverage of historical cardiac arrests using a volunteer-based network
of automated external defibrillators accessible to laypersons and
emergency dispatch centers. Circulation 2014;130:185967.
58. Malta Hansen C, Kragholm K, Pearson DA, et al. Association of
Bystander and First-responder intervention with survival after out-of-
hospital cardiac arrest in North Carolina, 2010-2013. JAMA
2015;314:25564.
59. Nas J, Thannhauser J, Herrmann JJ, et al. Changes in automated
external defibrillator use and survival after out-of-hospital cardiac
arrest in the Nijmegen area. Neth Heart J 2018;26:6005.
60. Bonnes JL, Brouwer MA, Navarese EP, et al. Manual cardiopulmonary
resuscitation versus CPR including a mechanical chest compression
device in out-of-hospital cardiac arrest: A comprehensive meta-
analysis from randomized and observational studies. Ann Emerg Med
201667: 349-60.e3.
61. Lamhaut L, Hutin A, Puymirat E, et al. A pre-hospital extracorporeal
cardio pulmonary resuscitation (ECPR) strategy for treatment of
refractory out hospital cardiac arrest: An observational study and
propensity analysis. Resuscitation 2017;117:10917.
62. Soar J, Nolan JP, Bottiger BW, et al. European resuscitation council
guidelines for resuscitation 2015: Section 3. Adult advanced life
support. Resuscitation 2015;95:10047.
R E S U S C I T A T I O N 1 4 8 ( 2 0 2 0 ) 3 1 3 13
